It was unclear precisely what the updated enforcement may look like, or what threats the company is responding to, in part because there is no manufacturing of Moderna vaccines other than by the company itself or its contractors
On Monday, Moderna announced that it was “updating” its pledge, opening up the possibility of enforcing its patents in middle- and high-income countries.
Image: Shutterstock
©2019 New York Times News Service